The clinical trial of the experimental vaccine against Covid-19 developed by AstraZeneca with the British University of Oxford has resumed in the United States, the only country where it was still suspended following the onset of a disease in a participating more than six weeks ago, the pharmaceutical group announced on Friday 23 October.
To read also: Vaccines: "We went very quickly without sacrificing safety"
"
The Medicines Agency (FDA) today authorized the resumption in the United States, following the resumption of trials in other countries in recent weeks,
" AstraZeneca announced in a statement.
The trial was suspended worldwide on September 6, but resumed in the UK and other countries in the days and weeks that followed.
See also
- Covid-19: Behind the scenes of the French vaccine factory
